002030.SZ
Daan Gene Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.39
−3.75%Margins
Gross margin
32.4%
EBITDA margin
-59.9%
EBIT margin
-128.2%
Net margin
-121.3%
FCF margin
12.9%
-12.7%
Return on equity
-10.7%
Return on assets
-13.2%
Return on invested capital
0.09x
Asset turnover
CNY 310.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026